do you even know why Immune-mediated pneumonitis occurs, there are many existing ailments and treatment which causes it, COPD, prior radiation therapy etc.. they all are risks, when you deal with cancer patients they would all have these pre existing ailments and conditions, that is why the clinical trails are divided into phases and each phase has its own outcomes etc, below is the truth and whatever you are alluding to is common in al clinical trails and never established that grade 5 was due to PD1
Phase I results demonstrated that PD1-Vaxx was:Safe and well toleratedCapable of inducing anti-PD1 antibodiesShown preclinically and clinically to potentially stimulate immune responses
IMU Price at posting:
1.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)